Form 4 for OPRX OptimizeRx Corp
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-01 · accession 0001628280-24-009407 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-06 | 2024-03-01 | OPRX | Silvestro Stephen L | Chief Commercial Off | F - Tax | $15.95 | -668 | 5,956 | -10% | -$10.7K |
| D | 2024-03-06 | 2024-03-01 | OPRX | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +1,927 | 6,624 | +41% | $0 |
| D | 2024-03-06 | 2024-03-01 | OPRX | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | -1,927 | 1,928 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | F | D | 668 | $15.95 | 5,956 | D | — | — | (F2) These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. |
| 2 | Common | Common Stock | 2024-03-01 | M | A | 1,927 | $0.00 | 6,624 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock. |
| 3 | Derivative | Restricted Stock Units | 2024-03-01 | M | D | 1,927 | $0.00 | 1,928 | D | — · — to — | 1,927 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock. (F3) The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date. |